Quick Answer
RHYTHM PHARMACEUTICALS, INC. reported Total Assets of $480.20 million for the year ending 2025.
- RHYTHM PHARMACEUTICALS, INC. showed an increase of +22.4% in Total Assets from 2024 to 2025.
- This data is from RHYTHM PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $34.80 million | Q1 2018: $139.44 million | Q2 2018: $291.75 million | Q3 2018: $277.73 million | Q1 2019: $236.50 million | Q2 2019: $210.89 million | Q3 2019: $177.53 million | Q1 2020: $273.76 million | Q2 2020: $243.49 million | Q3 2020: $215.48 million | Q1 2021: $422.21 million | Q2 2021: $388.39 million | Q3 2021: $355.82 million | Q1 2022: $284.82 million | Q2 2022: $277.68 million | Q3 2022: $389.61 million | Q1 2023: $345.68 million | Q2 2023: $309.94 million | Q3 2023: $354.20 million | Q1 2024: $258.65 million | Q2 2024: $381.85 million | Q3 2024: $363.57 million | Q1 2025: $386.69 million | Q2 2025: $372.73 million | Q3 2025: $506.87 million.
- Over the full 10 years of available data (2016 to 2025), RHYTHM PHARMACEUTICALS, INC.'s Total Assets has grown by 3,791.7%.
- Historical annual values: Fiscal year 2025: $480.20 million | Fiscal year 2024: $392.27 million | Fiscal year 2023: $332.75 million | Fiscal year 2022: $382.48 million | Fiscal year 2021: $329.52 million | Fiscal year 2020: $187.07 million | Fiscal year 2019: $308.52 million | Fiscal year 2018: $260.21 million | Fiscal year 2017: $151.74 million | Fiscal year 2016: $12.34 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: